AFP6h
European Commission Approves the Extension of the Indication of Palforzia® to the Treatment of Toddlers With Confirmed Peanut Allergy
Stallergenes Greer, a biopharmaceutical company specialising in allergen immunotherapy (AIT), announces that the European Commission (EC) has approved the extension of indication of Palforzia® ...
UVA Today1d
It’s in the Genes: Weight and Metabolism Determined by Genetics More Than Diet
A new study finds genetics has a greater impact on metabolism and weight than diet, which could challenge generic dietary ...
Ozempic ‘microdosing’ is the new weight-loss trend: Should you try it?
A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...
Everyday Health12d
FDA Approves First Medication for Obstructive Sleep Apnea
By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...
healthday12d
FDA Approves Tryngolza as Adjunct to Diet for Familial Chylomicronemia Syndrome
Tryngolza (olezarsen) has been approved by the U.S. Food and Drug Administration as an adjunct to diet to reduce trigl ...
FDA approves first generic liraglutide once-daily injection
The U.S. Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals) ...
Hindustan Times13d
Mono diet: Is this celebrity-approved trend worth the hype?
Victoria Beckham and Anushka Sharma follow a monotrophic diet, and we asked experts for their take on this celebrity-approved trend Victoria Beckham recently shared in an interview with the UK ...
Monthly Prescribing Reference14d
FDA Approves First Generic Version of Victoza for Type 2 Diabetes
The Food and Drug Administration (FDA) has approved Liraglutide Injection ... It is indicated for use as an adjunct to diet and exercise to improve glycemic control in adults and pediatric ...
Sleep apnea gets its first drug: Why US FDA approves weight loss drug for use
The United States Food and Drug Administration (FDA) has approved the weight-loss drug Tirzepatide — sold by the brand name ...
FDA approves first medication for obstructive sleep apnea — which also promotes weight loss
The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).
Fox News16d
FDA approves first medication for obstructive sleep apnea, which also promotes weight loss
On Dec. 20, the FDA announced that the agency has approved Eli Lilly's ... in adults with obesity. The drug is to be paired with a reduced-calorie diet and increased physical activity, the FDA ...